These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38467329)

  • 1. Scanning the Imaging Horizon for Hypertrophic Cardiomyopathy.
    Crean AM
    Can J Cardiol; 2024 May; 40(5):899-906. PubMed ID: 38467329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apical hypertrophic cardiomyopathy: clinical, electrocardiographic, scintigraphic, echocardiographic, and magnetic resonance imaging findings of a case.
    Sperling RT; Parker JA; Manning WJ; Danias PG
    J Cardiovasc Magn Reson; 2002; 4(2):291-5. PubMed ID: 12074145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging.
    Kherada N; Vinardell JM; Mihos CG; Santana O
    Echocardiography; 2017 Sep; 34(9):1392-1395. PubMed ID: 28573739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients.
    Kim EK; Lee SC; Hwang JW; Chang SA; Park SJ; On YK; Park KM; Choe YH; Kim SM; Park SW; Oh JK
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):678-86. PubMed ID: 26245912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-single photon emission computed tomography and contrast-enhanced magnetic resonance imaging to evaluate dissimilar features of apical hypertrophic cardiomyopathy.
    Okayama S; Kawata H; Sung JH; Okada S; Nishida T; Onoue K; Soeda T; Uemura S; Saito Y
    Cardiol J; 2010; 17(3):306-11. PubMed ID: 20535724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    Kamal MU; Riaz IB; Janardhanan R
    Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging cardiac hypertrophy in hypertrophic cardiomyopathy and its differential diagnosis.
    Rashdan L; Hodovan J; Masri A
    Curr Opin Cardiol; 2023 Sep; 38(5):397-404. PubMed ID: 37421401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study.
    Grover S; Lloyd R; Perry R; Lou PW; Haan E; Yeates L; Woodman R; Atherton JJ; Semsarian C; Selvanayagam JB
    Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):932-938. PubMed ID: 30668650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy.
    Lu DY; Yalçin H; Sivalokanathan S; Greenland GV; Vasquez N; Yalçin F; Zhao M; Valenta I; Ganz P; Pampaloni MH; Zimmerman S; Schindler TH; Abraham TP; Abraham MR
    J Nucl Cardiol; 2020 Dec; 27(6):2031-2043. PubMed ID: 30456498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
    Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic predictors of myocardial fibrosis and apical hypertrophic cardiomyopathy.
    Tangwiwat C; Kaolawanich Y; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12612. PubMed ID: 30403441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.
    Kramer CM; Appelbaum E; Desai MY; Desvigne-Nickens P; DiMarco JP; Friedrich MG; Geller N; Heckler S; Ho CY; Jerosch-Herold M; Ivey EA; Keleti J; Kim DY; Kolm P; Kwong RY; Maron MS; Schulz-Menger J; Piechnik S; Watkins H; Weintraub WS; Wu P; Neubauer S
    Am Heart J; 2015 Aug; 170(2):223-30. PubMed ID: 26299218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance.
    Amano Y; Kitamura M; Takano H; Yanagisawa F; Tachi M; Suzuki Y; Kumita S; Takayama M
    Magn Reson Med Sci; 2018 Apr; 17(2):120-131. PubMed ID: 29343659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography.
    Nagueh SF; Bierig SM; Budoff MJ; Desai M; Dilsizian V; Eidem B; Goldstein SA; Hung J; Maron MS; Ommen SR; Woo A; ; ; ;
    J Am Soc Echocardiogr; 2011 May; 24(5):473-98. PubMed ID: 21514501
    [No Abstract]   [Full Text] [Related]  

  • 17. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
    Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
    Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances.
    Reichek N
    Curr Opin Cardiol; 2015 Sep; 30(5):461-7. PubMed ID: 26154073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.
    Oliveira DC; Assunção FB; Santos AA; Nacif MS
    Arq Bras Cardiol; 2016 Aug; 107(2):163-72. PubMed ID: 27305111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.